News

Cohen & Steers Earnings Preview: Analysts Expect Positive Growth

Cohen & Steers Earnings Preview: Analysts Expect Positive Growth

What Investors Need to Know About Cohen & Steers Earnings

Cohen & Steers (NYSE: CNS) is set to announce its quarterly earnings report soon, and anticipation among investors is building. Analysts predict the company will report an earnings per share (EPS) of $0.78, which shows a promising outlook for the upcoming quarter.

Analysts’ Expectations

Investors are eagerly watching for the earnings announcement. The consensus is for Cohen & Steers to potentially beat EPS estimates, which could positively influence stock prices moving forward. It's essential for new investors to note that company guidance can be a significant factor in determining stock price movements.

Recent Earnings History

The previous year saw the company's EPS miss estimates by $0.02, resulting in a notable share price drop of 3.8% the following day. Understanding past performance can give investors valuable context for the upcoming release.

Stock Price Analysis

As of the latest report, shares of Cohen & Steers were trading around $67.04. Over the past year, the stock has experienced a decline of 36.23%. This downturn may unsettle long-term shareholders as they approach the upcoming earnings announcement.

Current Analyst Ratings

Keeping abreast of market expectations is crucial for investors. Currently, analysts have given Cohen & Steers an overall rating of Outperform. The average one-year price target stands at $71.25, suggesting a potential upside of 6.28% from current levels.

Peer Comparison

By comparing Cohen & Steers with its competitors, a clearer picture of market positioning emerges. Industry players such as Artisan Partners Asset, Federated Hermes, and Victory Capital Holdings offer insights into how analysts view the sector's performance.

  • Artisan Partners Asset currently holds a Neutral rating with an average price target of $45.5, suggesting potential downside.
  • Federated Hermes also maintains a Neutral rating with a price target of $52.6, signaling possible decline.
  • Victory Capital Holdings stands out with a Buy rating and a price target of $75.5, indicating potential growth.

Insights on Cohen & Steers

Delving deeper, Cohen & Steers specializes in real estate securities management, focusing on equity shares of various real estate investment trusts. The company's diverse portfolio showcases its ability to adapt to market demands, catering to both domestic and international investments.

Financial Overview

Market Capitalization: Currently, Cohen & Steers's market capitalization suggests it is smaller than many of its industry peers. This condition may result from various factors, such as growth perceptions and operational scale.

Revenue Insights: The last reported revenue growth rate stood at approximately 12.35%, signaling a favorable growth trend. However, the growth rate still trails behind several of its industry counterparts.

Profitability Metrics: The net margin for Cohen & Steers is recorded at 25.87%, which indicates some challenges in achieving industry-wide profitability standards.

Efficiency Indicators: The company's Return on Equity (ROE) reflects strong performance, reaching 7.11%, while the Return on Assets (ROA) is an impressive 4.65%, showcasing effective asset utilization.

Debt Management: Cohen & Steers demonstrates a conservative financial approach with a debt-to-equity ratio of 0.27, indicating a lower reliance on debt financing.

Conclusion and Investor Considerations

As the earnings report approaches, investors should closely monitor both the expected outcomes and broader market trends. The upcoming announcement could provide critical insights into the company's trajectory, influencing both investor sentiment and stock performance.

Frequently Asked Questions

What does CNS stand for?

CNS is the ticker symbol for Cohen & Steers, Inc., a company focusing on real estate securities among other investments.

What are analysts expecting for Cohen & Steers' earnings?

Analysts anticipate an earnings per share (EPS) of $0.78 for the upcoming quarter.

How has Cohen & Steers performed recently?

Recently, shares have decreased by 36.23% over the past year, indicating a challenging market environment.

What peer companies are comparable to Cohen & Steers?

Comparable companies include Artisan Partners Asset, Federated Hermes, and Victory Capital Holdings, each with varying analyst ratings.

Is Cohen & Steers a good investment?

With a consensus rating of Outperform from analysts, there is potential for growth, but investors should consider market conditions and past performance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Vishay Intertechnology Announces Exciting Dividend Update

Updated Category News Views 130

Vishay Intertechnology's Quarterly Dividend Announcement Vishay Intertechnology, Inc. (NYSE: VSH), a global leader in the manufacturing of discrete semiconductors and passive components, has recently made headlines by declaring a quarterly dividend. This announcement marks a significant moment for the company and its stakeholders as it reflects the steady financial health...

Continue Reading
Why Energy Brokerage Is One of the Most Overlooked Recession-Resistant Service Models

Updated Category Economy Views 48

Most discussions about recession-resistant business categories focus on the obvious choices: healthcare, essential retail, waste management, and food. What rarely comes up, despite being one of the cleaner examples of a service with demand that genuinely does not shrink during economic downturns, is commercial energy management. Specifically, the energy brokerage model is...

Continue Reading
Stephens Ups Guaranty Bancshares Target to $40 with Positive Outlook

Updated Category News Views 51

Stephens Upgrades Guaranty Bancshares' Price Target Recently, Stephens announced an increase in its target price for Guaranty Bancshares, Inc. (NYSE: GNTY) to $40.00. This updated estimation is an advancement from the previous target of $38.00. The positive adjustment comes after the company reported strong third-quarter earnings per share (EPS), which exceeded analysts'...

Continue Reading
Lightwave Logic Prepares for Special Call on March 13, 2025

Updated Category News Views 113

Lightwave Logic's Upcoming Special Call Announcement Lightwave Logic, Inc. (NASDAQ: LWLG) has exciting news to share as it prepares to host a special call on March 13, 2025. This event aims to shed light on the industry applications of electro-optic polymers, the company’s competitive positioning, and its strategic approach to market penetration. What to Expect from the...

Continue Reading
Accelerating Oncology: ONCare Alliance and Ovation.io Team Up

Updated Category News Views 106

Innovative Partnership Between ONCare Alliance and Ovation.io The ONCare Alliance and Ovation.io have embarked on an exciting collaboration to develop a multi-omics database and biobank aimed at accelerating biomarker discovery in the oncology field. This partnership combines the expertise of 32 independent oncology practices represented by ONCare with Ovation.io, a...

Continue Reading